Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

38 structures for Q9UHA3

Entry ID Method Resolution Chain Position Source
6LSS EM 323 A 7 1-163 PDB
6LU8 EM 313 A 7 1-163 PDB
8FKP EM 285 A SV 1-163 PDB
8FKQ EM 276 A SV 1-163 PDB
8FKR EM 289 A SV 1-163 PDB
8FKS EM 288 A SV 1-163 PDB
8FKT EM 281 A SV 1-163 PDB
8FKU EM 282 A SV 1-163 PDB
8FKV EM 247 A SV 1-163 PDB
8FKW EM 250 A SV 1-163 PDB
8FKX EM 259 A SV 1-163 PDB
8FKY EM 267 A SV 1-163 PDB
8FKZ EM 304 A SV 1-163 PDB
8FL0 EM 291 A SV 1-163 PDB
8FL2 EM 267 A SV 1-163 PDB
8FL3 EM 253 A SV 1-163 PDB
8FL4 EM 289 A SV 1-163 PDB
8FL6 EM 262 A SV 1-163 PDB
8FL7 EM 255 A SV 1-163 PDB
8FL9 EM 275 A SV 1-163 PDB
8FLA EM 263 A SV 1-163 PDB
8FLB EM 255 A SV 1-163 PDB
8FLC EM 276 A SV 1-163 PDB
8FLD EM 258 A SV 1-163 PDB
8FLE EM 248 A SV 1-163 PDB
8FLF EM 265 A SV 1-163 PDB
8IDT EM 280 A 7 1-163 PDB
8IDY EM 300 A 7 1-163 PDB
8IE3 EM 330 A 7 1-163 PDB
8INE EM 320 A 7 1-163 PDB
8INF EM 300 A 7 1-163 PDB
8INK EM 320 A 7 1-163 PDB
8IPD EM 320 A 7 1-163 PDB
8IPX EM 430 A 7 1-163 PDB
8IPY EM 320 A 7 1-163 PDB
8IR1 EM 330 A 7 1-163 PDB
8IR3 EM 350 A 7 1-163 PDB
AF-Q9UHA3-F1 Predicted AlphaFoldDB

144 variants for Q9UHA3

Variant ID(s) Position Change Description Diseaes Association Provenance
TCGA novel 1 M>? Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1262768278
CA392781648
3 I>M No ClinGen
gnomAD
CA7573482
rs777526919
4 E>G No ClinGen
ExAC
gnomAD
CA7573483
rs777526919
4 E>V No ClinGen
ExAC
gnomAD
CA7573481
rs756569215
7 Y>C No ClinGen
ExAC
gnomAD
CA392781607
rs1218707788
9 C>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs11540394
CA271241097
12 P>L No ClinGen
Ensembl
TCGA novel 12 P>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA271241098
rs1003962483
12 P>S No ClinGen
Ensembl
CA271241095
rs11540389
13 I>N No ClinGen
Ensembl
rs371629101
CA271241096
13 I>V No ClinGen
ESP
TOPMed
gnomAD
CA7573478
rs755577679
14 Y>C No ClinGen
ExAC
gnomAD
rs755577679
CA392781577
14 Y>F No ClinGen
ExAC
gnomAD
CA7573477
rs751998821
15 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA271241094
rs199532636
15 P>S No ClinGen
1000Genomes
TOPMed
rs766496104
CA392781567
16 G>A No ClinGen
ExAC
gnomAD
CA7573476
rs766496104
16 G>E No ClinGen
ExAC
gnomAD
CA392781558
rs762878339
17 H>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1278504670
CA392781556
18 G>C No ClinGen
TOPMed
rs765399239
CA271241093
CA7573473
19 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs1173400339
CA392781547
19 M>T No ClinGen
gnomAD
CA392781541
rs1178439610
20 M>T No ClinGen
gnomAD
rs761988262
CA7573472
20 M>V No ClinGen
ExAC
gnomAD
rs775326760
CA7573471
21 F>V No ClinGen
ExAC
gnomAD
CA392781529
rs1262414457
22 V>I No ClinGen
TOPMed
CA7573468
rs774087440
25 D>N No ClinGen
ExAC
gnomAD
rs200023487
CA7573440
28 V>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA271240616
rs17856255
29 F>I No ClinGen
ExAC
gnomAD
CA392781386
rs957387047
29 F>L No ClinGen
gnomAD
rs17856255
CA7573439
29 F>V No ClinGen
ExAC
gnomAD
CA271240614
rs17851202
30 R>G No ClinGen
TOPMed
CA271240613
rs111669877
30 R>T No ClinGen
Ensembl
rs778975431
CA7573438
37 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA271240612
rs939879035
37 H>Y No ClinGen
TOPMed
CA7573437
rs757258993
38 K>N No ClinGen
ExAC
gnomAD
CA392781308
rs1367145063
40 F>C No ClinGen
TOPMed
CA392781312
rs1347090778
40 F>L No ClinGen
gnomAD
TCGA novel 42 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA271240610
rs11540381
42 K>R No ClinGen
Ensembl
rs11540393
CA271240608
43 K>N No ClinGen
Ensembl
rs754119174
CA7573436
44 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
COSM191447
CA7573434
rs572620938
44 R>H large_intestine [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
rs572620938
CA392781280
44 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA271240607
rs17852590
45 N>D No ClinGen
Ensembl
CA7573433
rs772105282
45 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA392781265
rs1290751382
47 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA392781263
rs1464589332
47 R>H No ClinGen
gnomAD
CA392781252
rs751351733
49 V>F No ClinGen
ExAC
TOPMed
gnomAD
CA7573432
rs751351733
49 V>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 53 K>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1421858666
CA392781216
54 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1467469744
CA392781213
54 A>V No ClinGen
TOPMed
CA7573431
rs766272809
58 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs368924119
CA7573429
59 A>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs368924119
CA7573430
59 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1478045216
CA392781182
60 G>S No ClinGen
TOPMed
rs1261974696
CA392781149
64 T>I No ClinGen
TOPMed
gnomAD
CA392781145
rs1405220959
65 V>E No ClinGen
TOPMed
rs1459562317
CA392781146
65 V>L No ClinGen
gnomAD
TCGA novel 65 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7573386
rs759167715
66 D>V No ClinGen
ExAC
gnomAD
CA392781111
rs1310796598
68 S>* No ClinGen
TOPMed
rs1338047570
CA392781114
68 S>P No ClinGen
gnomAD
CA7573385
rs774755801
69 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA7573383
rs763374116
74 R>C No ClinGen
ExAC
gnomAD
rs145555296
CA7573382
74 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs145555296
CA392781068
74 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 74 R>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA271240432
rs1006463257
76 N>D No ClinGen
TOPMed
CA7573381
rs769784566
76 N>S No ClinGen
ExAC
gnomAD
CA7573380
rs370157846
77 E>A No ClinGen
ESP
ExAC
gnomAD
rs781386911
CA7573379
79 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs200616324
CA271240430
80 K>R No ClinGen
gnomAD
CA7573378
rs769044549
82 Q>E No ClinGen
ExAC
gnomAD
CA392781014
rs1197069200
82 Q>H No ClinGen
gnomAD
rs968465281
CA271240429
83 R>Q No ClinGen
TOPMed
CA7573377
rs747216897
84 E>Q No ClinGen
ExAC
TOPMed
gnomAD
CA271240428
rs17851390
86 W>R No ClinGen
Ensembl
rs778860442
CA7573376
87 N>H No ClinGen
ExAC
gnomAD
TCGA novel 87 N>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA7573351
rs754427012
91 D>G No ClinGen
ExAC
gnomAD
rs144437295
CA7573349
92 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 94 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750846016
CA7573347
96 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs371062419
CA271239766
98 E>D No ClinGen
TOPMed
gnomAD
CA271239764
rs145320361
99 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7573344
rs777224422
101 Q>E No ClinGen
ExAC
TOPMed
gnomAD
rs764295201
CA7573343
101 Q>H No ClinGen
ExAC
gnomAD
CA392780862
rs1462183225
103 R>C No ClinGen
gnomAD
rs199758477
CA7573342
103 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs775403419
CA7573341
104 Q>H No ClinGen
ExAC
gnomAD
CA271239763
rs113933212
104 Q>R No ClinGen
gnomAD
CA392780853
rs1470001086
105 A>T No ClinGen
TOPMed
gnomAD
CA271239762
rs968911646
107 F>L No ClinGen
Ensembl
rs772387456
CA7573340
109 M>I No ClinGen
ExAC
TOPMed
gnomAD
CA7573339
rs746065826
CA392780811
110 N>K No ClinGen
ExAC
gnomAD
CA7573321
rs774377773
115 N>T No ClinGen
ExAC
gnomAD
CA392780740
rs1209852668
119 Q>K No ClinGen
Ensembl
rs1057218932
CA271239541
120 K>E No ClinGen
TOPMed
gnomAD
rs1425383291
CA392780724
121 V>I No ClinGen
gnomAD
rs942533265
CA271239540
122 Q>E No ClinGen
gnomAD
CA392780708
rs1157012792
123 D>G No ClinGen
gnomAD
rs746905564
CA7573316
126 E>V No ClinGen
ExAC
gnomAD
CA271239538
rs139024218
132 H>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs911162056
CA271239539
132 H>N No ClinGen
gnomAD
CA7573315
rs139024218
132 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA7573314
rs757777074
133 L>F No ClinGen
ExAC
gnomAD
rs200024314
COSM309606
CA7573313
134 I>L lung [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
rs200024314
CA271239537
134 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA7573311
rs150727724
135 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1224212817
CA392780626
136 A>T No ClinGen
TOPMed
CA7573310
rs754306199
136 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA392780613
rs1327774181
138 L>F No ClinGen
TOPMed
CA392780604
rs1316315609
139 A>V No ClinGen
gnomAD
rs1458479049
CA392780589
140 G>A No ClinGen
TOPMed
rs1177662303
CA392780576
142 G>E No ClinGen
gnomAD
CA392780560
rs1191844668
144 Q>H No ClinGen
TOPMed
gnomAD
rs756376298
CA7573286
144 Q>R No ClinGen
ExAC
gnomAD
CA7573285
rs200847511
146 E>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA271239413
rs17852589
146 E>G No ClinGen
gnomAD
TCGA novel 146 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA392780551
rs1371882795
146 E>Q No ClinGen
TOPMed
COSM1373604
CA7573284
rs781511293
147 E>D Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA7573283
rs751183994
148 K>E No ClinGen
ExAC
gnomAD
rs1192808150
CA392780522
150 V>I No ClinGen
TOPMed
gnomAD
CA7573280
rs766430929
151 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA392780506
rs763224716
152 Q>P No ClinGen
ExAC
gnomAD
rs763224716
CA7573279
152 Q>R No ClinGen
ExAC
gnomAD
rs1249849823
CA392780494
154 Q>E No ClinGen
gnomAD
rs1249849823
CA392780495
154 Q>K No ClinGen
gnomAD
CA7573278
rs750572411
155 E>D No ClinGen
ExAC
gnomAD
CA392780482
rs1312479906
155 E>G No ClinGen
TOPMed
CA392780476
rs1348518536
156 D>G No ClinGen
gnomAD
rs1212669184
CA392780480
156 D>N No ClinGen
gnomAD
CA7573277
rs763887148
157 V>M No ClinGen
ExAC
gnomAD
CA7573276
rs760350791
158 D>E No ClinGen
ExAC
gnomAD
rs1299964957
CA392780464
158 D>G No ClinGen
gnomAD
CA7573275
rs775329023
159 M>T No ClinGen
ExAC
gnomAD
rs1358016739
CA392780459
159 M>V No ClinGen
TOPMed
rs771954608
CA7573274
160 E>A No ClinGen
ExAC
gnomAD
rs369049485
CA7573273
161 D>V No ClinGen
ESP
ExAC
gnomAD
rs774073894
CA7573272
162 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA7573271
rs770500399
164 P>K No ClinGen
ExAC
gnomAD
CA271239411
rs770500399
164 P>Q No ClinGen
ExAC
gnomAD

No associated diseases with Q9UHA3

2 regional properties for Q9UHA3

Type Name Position InterPro Accession
domain RsgA GTPase domain 102 - 279 IPR010914
domain Circularly permuted (CP)-type guanine nucleotide-binding (G) domain 114 - 276 IPR030378

Functions

Description
EC Number
Subcellular Localization
  • Nucleus, nucleolus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
ribosome An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.

1 GO annotations of molecular function

Name Definition
structural constituent of ribosome The action of a molecule that contributes to the structural integrity of the ribosome.

2 GO annotations of biological process

Name Definition
ribosomal large subunit biogenesis A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a large ribosomal subunit; includes transport to the sites of protein synthesis.
translation The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the ribosome, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q07915 RLP24 Ribosome biogenesis protein RLP24 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q3SZ12 RSL24D1 Probable ribosome biogenesis protein RLP24 Bos taurus (Bovine) PR
Q99L28 Rsl24d1 Probable ribosome biogenesis protein RLP24 Mus musculus (Mouse) PR
Q6P6G7 Rsl24d1 Probable ribosome biogenesis protein RLP24 Rattus norvegicus (Rat) PR
Q17606 rpl-24.2 Probable ribosome biogenesis protein RLP24 Caenorhabditis elegans PR
Q7ZTZ2 rsl24d1 Probable ribosome biogenesis protein RLP24 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MRIEKCYFCS GPIYPGHGMM FVRNDCKVFR FCKSKCHKNF KKKRNPRKVR WTKAFRKAAG
70 80 90 100 110 120
KELTVDNSFE FEKRRNEPIK YQRELWNKTI DAMKRVEEIK QKRQAKFIMN RLKKNKELQK
130 140 150 160
VQDIKEVKQN IHLIRAPLAG KGKQLEEKMV QQLQEDVDME DAP